Background: Prostaglandin E2 (PGE 2 ) regulates renin expression in renal juxtaglomerular cells. PGE 2 acts through Eprostanoid (EP) receptors in the renal collecting duct (CD) to regulate sodium and water balance. CD cells express EP1 and EP4, which are linked to protein kinase C (PKC) and PKA downstream pathways, respectively. Previous studies showed that the presence of renin in the CD, and that of PKC and PKA pathways, activate its expression. The (pro)renin receptor (PRR) is also expressed in CD cells, and its activation enhances cyclooxygenase-2 (COX-2) through extracellular signal-regulated kinase (ERK). We hypothesized that PGE 2 stimulates prorenin and renin synthesis leading to subsequent activation of PRR and upregulation of COX-2.
INTRODUCTION
R enin is mostly expressed in the juxtaglomerular cells (JG), which is the primary source of plasma renin activity and the limiting step for the activation of the renin-angiotensin system (RAS). 1, 2 Cyclooxygenase-2 (COX-2)-mediated Prostaglandin E2 (PGE 2 ) synthesizes in the macula densa (MD) and enhances renin expression in JG cells through the activation of E-prostanoid (EP) 4 receptor via cAMPprotein kinase A (PKA). 3, 4 After systemic RAS activation, angiotensin II (ANG II) stimulates Ca 2þ release 5 and protein kinase C (PKC) through type 1 receptor (AT1R) to inhibit renin synthesis in the JG cells. 6 Renin has also been detected in the collecting duct (CD), and its expression increases after ANG II stimulation 7, 8 via a mechanism mediated by AT1R and PKC activation. 9 ANG II also increases the expression of the (pro)renin receptor (PRR), which is abundantly expressed in CD intercalated cells. 10 PRR activation enhances COX-2 expression through mitogen-activated protein kinase (MAPK) pathways, 11 which finally leads to the increase in PGE 2 synthesis, as suggested previously. 12, 13 These mechanisms may enhance further formation of PGE 2 in the CD. PGE 2 exerts its effects through the following 4 types of EP receptors: the EP1, EP2, EP3 and EP4. 14 The EP4 receptors are predominantly expressed in the MD cells, whereas EP3 receptors are more abundant in the thick ascending limb. 15 The CD segment expresses EP1, EP3 and EP4 receptors. 16 EP1 activates PKC and increases intracellular Ca 2þ , whereas the EP3 receptor is coupled to a Gαi protein that inhibits cAMP formation. The EP4 receptor is coupled to a Gαs protein, which enhance cAMP formation. 16 It has been reported that M-1 cells express EP1, EP3 and EP4, but not EP2. 17 In ANG II-dependent hypertension, membranebound PRR, MAPK signaling, PGE 2 levels and COX-2 expression are augmented in the rat renal medulla mostly composed of CDs. 12 PGE2 may serve as a buffer against the hypertensinogenic and vasoconstricting effects of ANG II. 12, 13, 18 PRR activation by prorenin and renin increases COX-2 expression in conditions of high intrarenal ANG II. 12, 19 However, the role of PGE 2 in the regulation of PRR and renin expression and its effects on COX-2 abundance in CD cells have not been elucidated. In this study, we tested whether PGE 2 stimulates prorenin and renin synthesis leading to subsequent activation of PRR and upregulation of COX-2.
MATERIALS AND METHODS

M-1 Cell Culture and Reagents
The institutional review board of the Faculty of Science of the Pontificia Universidad Católica de Valparaíso approved the experimental design and treatments. M-1 cells (ATCC, VA) are a well-characterized CD cell line with phenotypic characteristics of cortical CD cells, including epithelial sodium channel (ENaC) and aquaporin-2 (AQP-2) expression. 20 Importantly, M-1 cells are composed of principal and intercalated cells, which express COX-2 21 EP1, EP3, EP4 17 prorenin-renin and PRR constitutively, 22 which make this cell line a good in vitro model to establish the role of the PRR-COX-2-PGE2 pathway on renin regulation. The M-1 cells were cultured as previously described. 9, 23 As shown in Figure 1A , M-1 cells express AQP-2 and can respond to vasopressin (AVP, 10 nM, 4 hour) increasing AQP-2 abundance in plasma membranes. Dose-response curves with different concentrations (10
À6 mol/L increased prorenin and renin at 4 hours (data not shown). Therefore, we harvested cells after 4, 8 and 12 hours of PGE 2 treatments. Transfections were performed 32 hours before treatments. PGE 2 was dissolved in dimethyl sulfoxide for stock and ethanol (vehicle) for dilutions. Controls were treated with vehicle with respective subsequent dilutions in cell culture media. Treatments were performed in the presence of indomethacin (1 mmoL/L) to block endogenous COX-1 and COX-2 activity and candesartan (1 mmoL/L) to rule out the possibility of endogenous ANG II formation and AT1R activation. SC119220 and L161982 were purchased from Cayman (Cayman, Ann Arbor, MI) and used according to the company's recommendations and IC50 described in the literature. 24 Immunofluorescence Studies M-1 cells were fixed in cold methanol. Afterward, they were blocked and stained with rabbit anti-ATP6AP2 (Catalogue number [Cat. no.] HPA003156, Sigma, St. Louis, Missouri), mouse anti-COX-2 (Cat. no. sc-1747 Santa Cruz) and detected with Alexa Fluor 594 or 488 conjugated to antirabbit or antimouse IgG (Invitrogen, Carlsbad, CA), accordingly. Primary antibodies used for characterization of M-1 cells were rabbit anti-AQP-2 (Cat. no. 178612, Calbiochem, San Diego, CA) and rabbit antirenin (sc H-105, Santa Cruz Biotechnology, Santa Cruz, CA). Samples were counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI, Invitrogen, Carlsbad, CA). Negative controls were obtained by omission of the specific primary antibody. NIS elements analysis software (Nikon) was used to quantify PRR-COX-2 colocalization intensity by measuring the merging area in 6 fields (Â40). Results are expressed as the COX-2-PRR co-localization intensity after PGE 2 treatment with or without PRR small hairpin RNA (shRNA) versus number of total cells ( Figure 4C ).
Western Blot Analysis for Phospho-ERK1/2 and Total ERK1/2, COX-2 and PRR After treatments, M-1 cells were homogenized in lysis buffer (mmoL/L: NaCl 150, Tris 50, dithiothreitol 100, 1% NP-40 and 1% protease inhibitor cocktail, Sigma) and complete protease inhibitor mixture tablet with 1 mM ethylenediaminetetraacetic acid. Lysates were sonicated for 10 seconds on ice and centrifuged at 5,000 rpm for 10 minutes. The supernatants were measured for protein using the Bradford Protein Assay (Bio-Rad). A total of 20 mg of total protein was separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (10% or 12%), transferred to nitrocellulose membrane (Amersham Biosciences, Freiburg, Germany), probed with renin polyclonal IgG B-12 antibody (sc-133145, Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-ATP6AP2 (Cat. no. HPA003156, Sigma), mouse anti-COX-2 (Cat. no. sc-1747 Santa Cruz), mouse anti-phospho-p44/42 extracellular signal-regulated kinase (ERK1/2) (Thr202/Tyr204) antibody (Cat. no. 91065, Cell Signaling Technology, Beverly, MA), rabbit antitotal extracellular signal-regulated kinase (ERK) (Cat. no. 9122, Cell Signaling Technology, Beverly, MA), were revealed using an enhanced chemiluminescence system. Band identity was confirmed by using mouse recombinant prorenin (AnaSpec, Fremont, CA), renin (Lee Biosolutions, St. Louis, MO), COX-2 (human COX-2 cat. no. 60122) and a recombinant PRR peptide. Resulting bands were compared with molecular weight standards (M. Biosources, San Diego, CA). Densitometry was performed with ImageJ software and normalized to β-actin and quantified with respect to controls. Results were expressed as percentage versus control (100%).
PRR Knockdown Using Transient Transfections of GFP-shRNA-PRR
Silencing of PRR expression was performed using SureSilencingTM shRNA plasmid for Mouse Atp6ap2 (Cat. no. KM26726, SABioscience, Qiagen, Valencia, CA), according to manufacturer's instructions. Subconfluent cells (60%) were transfected 32 hour before treatments. Green fluorescent protein (GFP) positive cells ( Figure 3A ) confirmed effectiveness of transfections, which reached a rate 70 Ϯ 8% (n ¼ 10). Effectiveness of PRR silencing was also verified by band intensity compared with cells transfected with scrambleshRNA ( Figure 3B ). Cell viability after PRR knockdown (48 hour) was assessed by AlamarBlue Cell Viability Reagent (ThermoFisher DAL 1025) demonstrating no effects in death cell counting.
Statistical Analysis
For western blot and mRNA levels, an average of 6 independent observations were performed for each treatment and represented as percentage versus controls (100%). Data were evaluated by the Grubb test, followed, when appropriate, by paired and unpaired Student's t test or by 1-way analysis of variance with Tukey posttest. Significance was defined as P o 0.05. No significant differences are expressed as "NS." Results are expressed as mean Ϯ standard error of the mean. 
RESULTS
Characterization of the M-1 Cells and Western Blot
Band Identity M-1 cells are a well-characterized CD cell line with phenotypic characteristics of cortical CD cells, including ENaC and AQP-2 expression. 20 As shown in Figure 1A , M-1 cells express AQP-2 and can respond to AVP (10 nM, 4 hours), increasing AQP-2 abundance in plasma membrane. M-1 cells also express PRR that has been described in intercalated cells and reninprorenin staining in principal cells ( Figure 1B) . To further confirm the specificity and identity of western blot bands, we used recombinant proteins to clarify the expected molecular weight. As shown in Figure 1C , recombinant prorenin was observed near 45 kDa, whereas renin was detected near 38 kDa; this agrees with our previous reports. 9 Full-length recombinant PRR was detected at 28 kDa. As expected, COX-2 positive control was detected at 70 kDa.
Micromolar Concentrations of PGE 2 Increases
Prorenin and Renin Protein Levels at 4 Hours But Not at 12 Hours Figure 2A shows a time profile of prorenin-renin protein expression. Prorenin and renin protein levels reached a significant upregulation at 4 hours (prorenin: 170 Ϯ 12%, P o 0.05 versus control; renin 155 Ϯ 9%, P o 0.05 versus control). The prorenin band was still augmented at 8 hours after PGE 2 treatment; however, the renin band was not significantly different from control levels as shown in the quantification plot ( Figure 2B ). Along with prorenin and renin, protein induction was observed 4 and 8 hours after PGE 2 treatment, and COX-2 protein levels were maximally increased at 12 hours (187 Ϯ 11 versus 100 Ϯ 13%, P o 0.05). A significant reduction in COX-2 protein abundance was observed at 4 hours after PGE 2 treatment (81 Ϯ 5 versus 100 Ϯ 11%, P o 0.05). Interestingly, PRR expression was augmented at 12 hours after PGE 2 treatment (137 Ϯ 9 versus 100 Ϯ 15%, P o 0.05, Figure 2A and B) . Similarly, ERK1/2 phosphorylation levels were maximally augmented at 12 hours ( Figure 2C ).
PRR Knockdown Prevented COX-2 Upregulation Observed After 12 Hours of PGE 2 Treatment
To test whether the increased ERK pathway and COX-2 expression was due to PRR stimulation, we performed transfections with shRNA-PRR to knockdown PRR expression. Figure 3A shows GFP positive cells transfected with shRNA-PRR. The percentage of GFP positive cells was 70 Ϯ 8%. A reduction of 73 Ϯ 14% (n ¼ 6) in the expression of PRR was observed by densitometric analysis ( Figure 3B ). As shown in Figure 4B , PRR (red) is expressed in M-1 cells (probably intercalated cells), which are also positive for COX-2 (green). PRR was observed in the plasma membrane (arrows) and in a perinuclear distribution (asterisk) probably associated to the V-ATPase; this was previously described in rat primary cultured inner medullary CD cells. 13 PRR shRNA impairs COX-2 upregulation ( Figure 4A and C) at 12 hour (107 Ϯ 8% versus 100 Ϯ 13%, P ¼ nonsignificant, Figure 4D ) and blunted ERK1/2 phosphorylation ( Figure 4E) . A transient decrease in COX-2 expression was also observed at 4 hour, indicating that PGE 2 causes an initial reduction of COX-2 expression as described earlier. 15 
Pharmacological Inhibition of EP1 and EP4 Partially Prevents Prorenin-Renin Upregulation
To look for a PGE 2 receptor responsible for starting the pathway leading to increased COX-2 in M-1 cells, we blockaded pharmacological EP1 and EP4 (PKC-Ca 2þ and cAMP pathway, respectively) to see whether prorenin or renin abundance could be ameliorated. As shown in Figure 5 , EP1 and EP4 inhibitors at doses described in the literature suppressed prorenin and renin upregulation, suggesting that PRR stimulation might be reduced leading to an impairment of COX-2 upregulation.
DISCUSSION
We have demonstrated that PGE 2 stimulates prorenin and renin protein levels at mmolar concentrations in M-1 CD cells. This stimulation was seen at 4 hours, whereas ERK1/2 phosphorylation and COX-2 protein levels were increased during a late phase (12 hours). Moreover, COX-2 was decreased after PGE 2 treatment below control levels in agreement with previous reports indicating that EP3 downregulates COX-2 in thick ascending limbs. 25 Our findings indicate that PGE 2 treatment causes a temporal biphasic expression pattern of COX-2 that depends on PRR activation, as PRR silencing prevented this effect.
Actions of PGE 2 in the kidney are related to the stimulation of renin synthesis in JG cells 3, 26, 27 and the regulation of tubular sodium and water transport. 28 EP receptors (EP1-4) are coupled to different signaling pathways. It has been shown that M-1 CD cells express EP1, EP3 and EP4. 17 We have previously demonstrated that activation of the AT1 receptor increases prorenin and renin expression via cAMP accumulation, which is dependent on PKC activity. 9, 23 In the MD, the activation of EP4 receptor enhances cAMP formation and activates the cAMP-CREB pathway and renin synthesis in JG cells. 29 It is likely that the effect of PGE 2 might also be mediated by stimulation of EP1 and EP4 receptors and activation of PKC and cAMP, respectively, which finally leads to the upregulation or prorenin and renin protein.
More recently, we reported that actions of AVP require the intact activity of PKC to enhance prorenin and renin protein expression in CD cells. 9 Indeed, PKC potentiates PKA-mediated signals responsible for AQP-2 expression in the plasma membrane in CD cells. 30 PGE 2 -mediated increases in renin expression in the CD might be of functional significance in the regulatory buffer system in the CD. We previously revealed that COX-2 expression is upregulated by direct activation of the PRR independently of the activation of AT1 receptors in rat primary cultured renal inner medullary cells. 13 We have shown that COX-2 is expressed in intercalated cells of the CD. 12, 13 The expression of renin and prorenin in the principal cells of the CD is augmented during high ANG II states 7, 31, 32 and is secreted in the intratubular fluid. 33 Renin and prorenin are detected in the cell culture media 9, 23 suggesting that augmented prorenin and renin secretion may activate the PRR in the plasma membrane of the neighboring intercalated cell. The activation of the PRR by prorenin increases the expression of COX-2 via activation of MAPK. 12, 13 Accordingly, it increases in prorenin or renin secretion by principal cells activated PRR, which augments COX-2 and PGE 2 production in the renal medulla serving as a buffer mechanism against the vasoconstricting and antinatriuretic effects of activated RAS as suggested previously. 12, 18, 22, 34 The M-1 CD cell line has cortical origin and expresses ENaC and AQP-2; they are also composed of intercalated cells. 20 More importantly, they express all the components common in medullary and cortical CDs, such as prorenin, renin, PRR, COX-2 and EP receptors studied in this report, representing a good in vitro model. Here, we showed that a single PGE 2 treatment mediates an early upregulation of prorenin and renin (4 hours) and the upregulation of COX-2 during later stages (12 hours). Then, it is possible that the prorenin and renin bind to PRR and activate ERK1/2 pathway and COX-2. This hypothesis was demonstrated by PRR expression knockdown, which dramatically blunted COX-2 upregulation during the late phase (12 hours). Interestingly, PRR was also upregulated at 12 hours ( Figure 1A and B), in agreement with recent studies from Yang's group, showing that PGE 2 upregulates PRR. 35 Stimulation of renin synthesis via PGE 2 may lead to a positive feedback mechanism by which continuous stimulation of its expression contributes to further activation of EP receptors by COX-2-mediated increases in PGE 2 . Importantly, downregulation of COX-2 by EP receptors has been described in thick ascending limb. 15 Our data suggest that PGE 2 may be the initial stimuli to promote prorenin-renin-mediated stimulation of PRR and COX-2 augmentation in CD cells. Our data suggest that this stimulation is mediated by EP1 and EP4 receptors ( Figure 5 ) that are linked to the stimulation of PKC-Ca 2þ and stimulation of cAMP formation within the cell, and both mechanisms seem to be involved in renin synthesis in the CD. 23 We previously showed that during the early phase of ANG II-dependent hypertension, membrane-bound PRR and COX-2 are augmented in the renal medullary tissues. 12 This increased COX-2 expression forms PGE 2 and PGI 2 , which buffers the hypertensinogenic and vasoconstricting effects of ANG II during this early period by inhibiting ENaC activity and expression. [36] [37] [38] [39] However, this process is followed by reduced PRR expression associated with reduced COX-2 expression during later stages of ANG II hypertension. 12 Recent evidence from Wang et al 35 showed that increases in systolic blood pressure with ANG II infusion was attenuated by the COX-2 inhibition and was associated with decreases in renal medullary PRR expression. Thus, feedback interactions between PGE 2 -mediated increases in renin expression and PRR-COX-2 expression during the early phase of ANG FIGURE 6 . Hypothetical model of the mechanism of prostaglandin E2 (PGE 2 )-dependent regulation of renin and subsequent upregulation of cyclooxygenase-2 (COX-2) via (pro)renin receptor (PRR) leading to further PGE 2 synthesis as a buffer mechanism against the activation effects of the renin-angiotensin system in vivo. Our data suggest that PGE 2 enhances prorenin-renin synthesis. The membrane-bound PRR promotes signal transduction when activated by prorenin or renin leading to COX-2 upregulation. The activation of EP1 inhibits the activity of the epithelial sodium channel (ENaC) promoting natriuresis, but it also might stimulate prorenin-renin synthesis. COX-2 is also greatly augmented in collecting duct cells during the early phase of the activation of the renin-angiotensin system. ACE, angiotensin-converting enzyme; AC, adenylate cyclase; Ang, angiotensin; AT1R, angiotensin II type I receptor; Ca2+, Calcium ion; cAMP, cyclic adenosine monophosphate; CRE, cAMP response element; DAG, diacylglycerol; IP3, inositol trisphosphate; MAPK, mitogen-activated protein kinases; Na+, sodium ion; P-CREB, phospho-cAMP response element-binding protein; PIP2, phosphatidylinositol 4,5-bisphosphate; PKA, protein kinase A; PCKα, protein kinase C-alpha.
II hypertension may be able to buffer the actions of ANG II ( Figure 6 ).
PRR activation upregulates COX-2 via ERK1/2 pathways, 11 which contribute to inflammatory processes in the kidney. Therefore, it is important to evaluate the effects of PRR activation in the distal nephron because the synthesis of prorenin is augmented in the CD during diabetic nephropathy, 40 which may contribute to the activation of PRR and signaling pathways that promote tubular damage. Ohashi et al 41 reported that plasmasoluble PRR reflects renal damage. In agreement with our previous studies, plasma-soluble PRR might have a role in intratubular ANG II formation leading to further stimulation of renin synthesis in the CD. 18 Another study from Huang et al 42 described the enhanced, intrarenal receptor-mediated prorenin activation in chronic progressive nephritis in rats. On the contrary, the role of PGE 2 during early activation of prorenin-dependent PRR activation may represent a nonphysiopathological role, which may help to buffer hypertensinogenic responses.
In summary, these results demonstrated that PGE 2 increases prorenin and renin protein levels in M-1 CD cells, and the increased prorenin and renin may subsequently increase intracellular signaling pathways mediated by PRR, stimulating COX-2 and further PGE 2 synthesis. Distal intraluminal secretion of prorenin or renin can stimulate the PRR-mediated upregulation of COX-2 and PGE 2 synthesis in vivo. Increases in prorenin, renin, PRR and COX-2 in the CD during the early phase of hypertension support this concept and reflect the complex regulation of natriuretic and prohypertensive effects of the interplay among COX-2, PRR and renin.
